Wikidata entity: Q65345943
Quantities
| P2899 | minimum age | 18 |
| P1132 | number of participants | 545 |
| P6099 | clinical trial phase | ... | Q42824827 (phase III clinical trial) | phase III clinical trial |
| P17 | country | ... | Q30 (United States) | United States |
| P582 | end time | ... | 2016-05-01 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P1050 | medical condition | ... | Q179945 (psoriasis) | psoriasis |
| P6153 | research site | ... | Q30269796 (Grekin Skin Institute) | Grekin Skin Institute |
| P6153 | research site | ... | Q30270033 (PMG Research) | PMG Research |
| P6153 | research site | ... | Q30270616 (Windsor Clinical Research) | Windsor Clinical Research |
| P1813 | short name | Monolingualtext | PsOsim | ??? |
| P580 | start time | ... | 2015-08-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis | ??? |
| P3098 | ClinicalTrials.gov ID | NCT02489227 |
Why not click here or view trends?
log id: 5124916